We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

116 hedge funds and large institutions have $123M invested in G1 Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $550K | Put options by funds: $341K

50% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 24

12% more funds holding

Funds holding: 104 → 116 (+12)

7% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 30

57% less capital invested

Capital invested by funds: $287M → $123M (-$164M)

Holders
116
Holders Change
+12
Holders Change %
+11.54%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
32
Reduced
30
Closed
24
Calls
$550K
Puts
$341K
Net Calls
+$209K
Net Calls Change
-$537K

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$6.3M
2
Renaissance Technologies
Renaissance Technologies
New York
+$4.56M
3
Millennium Management
Millennium Management
New York
+$4.18M
4
Marshall Wace
Marshall Wace
United Kingdom
+$3.04M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.93M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$12.1M
2
PBA
Paradigm Biocapital Advisors
New York
-$11M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$4.32M
4
CSS
Cubist Systematic Strategies
Connecticut
-$3.11M
5
EI
EAM Investors
California
-$2.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
EGM
51
Engineers Gate Manager
New York
$253K +$169K +20,190 +77%
JF
52
Jump Financial
Illinois
$242K +$42.8K +5,103 +13%
S
53
SignatureFD
Georgia
$242K -$880 -105 -0.2%
RJFSA
54
Raymond James Financial Services Advisors
Florida
$240K -$65.7K -7,835 -15%
State of Wisconsin Investment Board
55
State of Wisconsin Investment Board
Wisconsin
$233K +$360K +42,951 New
BC
56
Birchview Capital
Vermont
$217K – – –
TI
57
Trexquant Investment
Connecticut
$214K -$233K -27,828 -41%
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$202K +$312K +37,229 New
BWA
59
BDO Wealth Advisors
Florida
$191K – – –
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$190K -$61.9K -7,382 -17%
CS
61
Credit Suisse
Switzerland
$188K +$290K +34,589 New
Acadian Asset Management
62
Acadian Asset Management
Massachusetts
$165K +$255K +30,475 New
QT
63
Quantbot Technologies
New York
$159K +$240K +28,685 +5,254%
6CM
64
683 Capital Management
New York
$148K +$229K +27,292 New
Barclays
65
Barclays
United Kingdom
$144K -$730K -87,156 -77%
Wells Fargo
66
Wells Fargo
California
$138K -$242K -28,869 -53%
CNBT
67
Cornerstone National Bank & Trust
Illinois
$136K – – –
MFG
68
Magnus Financial Group
New York
$136K – – –
Citigroup
69
Citigroup
New York
$133K -$862K -102,905 -81%
AGM
70
Alpine Global Management
New York
$131K +$202K +24,085 New
Man Group
71
Man Group
United Kingdom
$129K +$199K +23,760 New
FRM
72
Fox Run Management
Connecticut
$128K +$197K +23,542 New
FSA
73
Franklin Street Advisors
North Carolina
$126K – – –
LIP
74
Lighthouse Investment Partners
Florida
$124K +$192K +22,920 New
Bank of New York Mellon
75
Bank of New York Mellon
New York
$105K -$1.7K -203 -1%
1 2
3
4 5

GTHX Hedge Fund Activity: Q4 2022 in Review

116 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q4 2022, worth a combined $123M — down 57% from $287M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new GTHX positions and 24 closed out — a net gain of 12 holders — while 32 added to existing stakes and 30 trimmed.

The largest buyer was Woodline Partners, adding an estimated $6.3M. The largest seller was State Street, cutting an estimated $12.1M.

  • 116 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q4 2022, up from 104 in Q3 2022.
  • Funds reported $123M of G1 Therapeutics, Inc. Common Stock stock for Q4 2022, down 57% quarter-over-quarter.
  • 36 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q4 2022 and 24 closed out, a net change of +12 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q4 2022 was Woodline Partners, an estimated $6.3M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q4 2022 was State Street, an estimated $12.1M sold.

Based on aggregated 13F filings for Q4 2022.